文献
J-GLOBAL ID:202202284350790742
整理番号:22A0447872
血友病B患者における延長半減期因子IX濃縮物の個別化投与のための限定サンプリング戦略のin silico評価【JST・京大機械翻訳】
In silico evaluation of limited sampling strategies for individualized dosing of extended half-life factor IX concentrates in hemophilia B patients
著者 (8件):
Preijers T.
(Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands)
,
van Spengler M. W. F.
(Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands)
,
Meijer K.
(Department of Pediatric Hematology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands)
,
Fijnvandraat K.
(Department of Hematology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands)
,
Fischer K.
(Van Creveldkliniek University Medical Center Utrecht, Utrecht, The Netherlands)
,
Leebeek F. W. G.
(Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands)
,
Cnossen M. H.
(Department of Pediatric Hematology, Erasmus University Medical Center, Sophia Children’s Hospital, Rotterdam, The Netherlands)
,
Mathot R. A. A.
(Hospital Pharmacy-Clinical Pharmacology, Amsterdam University Medical Center, Amsterdam, The Netherlands)
資料名:
European Journal of Clinical Pharmacology
(European Journal of Clinical Pharmacology)
巻:
78
号:
2
ページ:
237-249
発行年:
2022年
JST資料番号:
A0208A
ISSN:
0031-6970
CODEN:
EJCPAS
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
ドイツ (DEU)
言語:
英語 (EN)